Differential immunogenicity of HLA class I alloantigens for the humoral versus the cellular immune response: "Towards tailor-made HLA mismatching"'

被引:12
作者
Claas, FHJ
Roelen, DL
Mulder, A
Doxiadis, IIN
Oudshoorn, M
Heemskerk, M
机构
[1] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, NL-2300 RC Leiden, Netherlands
[2] Europdonor Fdn, Leiden, Netherlands
关键词
D O I
10.1016/j.humimm.2006.03.004
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenicity of an individual human leukocyte antigen (HLA) class I mismatch is different for the cellular and the humoral alloimmune responses. The consequence is that the same antigen can induce a strong antibody response and no cytotoxic T lymphocyte reactivity, but the reverse can occur also. Exact knowledge of the immunogenicity of an HLA mismatch for an individual patient can lead to a strategy of tailor-made HLA mismatching if no HLA identical donor is available. Depending on the clinical situation, one should select a donor with HLA mismatches according to the humoral or cellular mismatch algorithm.
引用
收藏
页码:424 / 429
页数:6
相关论文
共 35 条
  • [11] Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response
    Heemskerk, MBA
    Roelen, DL
    Dankers, MKA
    van Rood, JJ
    Claas, FHJ
    Doxiadis, IIN
    Oudshoorn, M
    [J]. HUMAN IMMUNOLOGY, 2005, 66 (09) : 969 - 976
  • [12] The HistoCheck algorithm does not predict T-cell alloreactivity in vitro
    Heemskerk, MBA
    Doxiadis, HN
    [J]. BONE MARROW TRANSPLANTATION, 2005, 36 (10) : 927 - 928
  • [13] How to improve the search for an unrelated haematopoietic stem cell donor.: Faster is better than more!
    Heemskerk, MBA
    van Walraven, SM
    Cornelissen, JJ
    Barge, RMY
    Bredius, RGM
    Egeler, RM
    Lie, JLWT
    Révész, T
    Sintnicolaas, K
    Wulffraat, NM
    Donker, AE
    Hoogerbrugge, PM
    van Rood, JJ
    Claas, FHJ
    Oudshoorn, M
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 645 - 652
  • [14] Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success
    Hiby, SE
    Walker, JJ
    O'Shaughnessy, KM
    Redman, CWG
    Carrington, M
    Trowsdale, J
    Moffett, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (08) : 957 - 965
  • [15] HYPERACUTE REJECTION OF KIDNEY ALLOGRAFTS ASSOCIATED WITH PRE-EXISTING HUMORAL ANTIBODIES AGAINST DONOR CELLS
    KISSMEYE, F
    OLSEN, S
    PETERSEN, VP
    FJELDBORG, O
    [J]. LANCET, 1966, 2 (7465) : 662 - +
  • [16] A naturally selected dimorphism within the HLA-B44 supertype alters class I structure, peptide repertoire, and T cell recognition
    Macdonald, WA
    Purcell, AW
    Misfud, NA
    Ely, LK
    Williams, DS
    Chang, LN
    Gorman, J
    Clements, CS
    Kjer-Nielsen, L
    Koelle, DM
    Burrows, SR
    Tait, BD
    Holdsworth, R
    Brooks, AG
    Lovrecz, GO
    Lu, L
    Rossjohn, J
    McCluskey, J
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (05) : 679 - 691
  • [17] Maruya E, 1993, Clin Transpl, P511
  • [18] MILLARD FE, 1987, BLOOD, V70, P1495
  • [19] Prevention and management of platelet transfusion refractoriness
    Novotny, VMJ
    [J]. VOX SANGUINIS, 1999, 76 (01) : 1 - 13
  • [20] Functional versus structural matching: Can the CTLp test be replaced by HLA allele typing?
    Oudshoorn, M
    Doxiadis, IIN
    van den Berg-Loonen, PM
    Voorter, CEM
    Verduyn, W
    Claas, FHJ
    [J]. HUMAN IMMUNOLOGY, 2002, 63 (03) : 176 - 184